Interpol teams up with pharma


International police service Interpol is teaming up with 29 drug companies to combat the trade in fake medicines.

The group will spend €4.5 million (£3.9 million) to create a pharmaceutical crime programme, which will build on the work of Interpol's Medical Product Counterfeiting and Pharmaceutical Crime (MPCPC) unit.

The programme will seek to raise awareness of the dangers of fake drugs, particularly those bought online. According to the World Health Organization, in more than 50% of cases, medicines purchased over the internet from illegal sites that conceal their physical addresses are counterfeit.

Counterfeit cough syrup and other medicines laced with diethylene glycol have caused eight mass poisonings around the world. In 2006, more than 100 people in Panama, many of them children, died after taking contaminated cough syrup. In 2012, over 100 heart patients in Pakistan died after taking fake medicine.

Pharmaceutical crime includes manufacture, trade and distribution of fake, stolen or illicit medicines or medical devices.


Related Content

Weathering the storm

6 January 2014 Business

news image

Pharmaceutical industry roundup 2013

Chinese police seize £222m of fake drugs

20 December 2013 Business

news image

1300 people are arrested in a nationwide crackdown on counterfeit medicines

Most Read

Complex amines made easy (and cheap)

22 May 2015 Research

news image

Iron-catalysed cross-coupling brings together nitroarenes and olefins in a single step in boon for drug makers

Opiate-producing yeast raises spectre of 'home-brewed heroin'

18 May 2015 News and Analysis

news image

Warnings that completion of final steps in opiate biosynthesis could be a double-edged sword

Most Commented

The nuclear danger of iodine

20 May 2015 Comments

news image

It may not be an element you think of as problematic. But, as Mark Foreman explains, iodine causes very complicated problems ...

Opiate-producing yeast raises spectre of 'home-brewed heroin'

18 May 2015 News and Analysis

news image

Warnings that completion of final steps in opiate biosynthesis could be a double-edged sword